265
Views
3
CrossRef citations to date
0
Altmetric
Original research

Patient preferences for elagolix and leuprolide for treating endometriosis-related pain in the United States

ORCID Icon, , &
Pages 1091-1099 | Received 05 May 2020, Accepted 01 Oct 2020, Published online: 03 Nov 2020

References

  • Fuldeore MJ, Soliman AM. Prevalence and symptomatic burden of diagnosed endometriosis in the United States: national estimates from a cross-sectional survey of 59,411 women. Gynecol Obstet Invest. 2017;82(5):453–461.
  • Sinaii N, Plumb K, Cotton L, et al. Differences in characteristics among 1,000 women with endometriosis based on extent of disease. Fertil Steril. 2008 Mar;89(3):538–545.
  • Morotti M, Vincent K, Brawn J, et al. Peripheral changes in endometriosis-associated pain. Hum Reprod Update. 2014 Sep-Oct;20(5):717–736.
  • Chiantera V, Abesadze E, Mechsner S. How to understand the complexity of endometriosis-related pain. J Endometr Pelvic Pain Disord. 2018;9(1):30–38.
  • Hansen KA, Chalpe A, Eyster KM. Management of endometriosis-associated pain. Clin Obstet Gynecol. 2010 Jun;53(2):439–448.
  • Ferrero S, Barra F, Leone RMU. Current and emerging therapeutics for the management of endometriosis. Drugs. 2018 Jul;78(10):995–1012.
  • Leyland N, Surrey E, Soliman AM, et al. Baseline burden of endometriosis-associated pain among women in two phase 3 elagolix studies [10Q]. Obstet Gynecol. 2018;131:186S–187S.
  • Taylor HS, Giudice LC, Lessey BA, et al. Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist. N Engl J Med. 2017 Jul 6;377(1):28–40.
  • Lamb YN. Elagolix: first global approval. Drugs. 2018 Sep;78(14):1501–1508.
  • Lupron Depot Prescribing Information. US food and drug administration. [cited 2018 Apr]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020708s035lbl.pdf
  • Crosignani PG, Luciano A, Ray A, et al. Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain. Hum Reprod. 2006 Jan;21(1):248–256.
  • Schlaff WD, Carson SA, Luciano A, et al. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain. Fertil Steril. 2006 Feb;85(2):314–325.
  • Ho MP, Gonzalez JM, Lerner HP, et al. Incorporating patient-preference evidence into regulatory decision making. Surg Endosc. 2015 Oct;29(10):2984–2993.
  • Poulos C, Soliman AM, Renz CL, et al. Patient preferences for endometriosis pain treatments in the United States. Value Health. 2019 Jun;22(6):728–738.
  • Bridges JF, Hauber AB, Marshall D, et al. Conjoint analysis applications in health–a checklist: a report of the ISPOR good research practices for conjoint analysis task force. Value Health. 2011 Jun;14(4):403–413.
  • Hauber AB, Gonzalez JM, Groothuis-Oudshoorn CG, et al. Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR conjoint analysis good research practices task force. Value Health. 2016 Jun;19(4):300–315.
  • Wheeler JM, Knittle JD, Miller JD. Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis. Efficacy results. Am J Obstet Gynecol. 1992;167(5):1367–1371.
  • Wheeler JM, Knittle JD, Miller JD. Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: a multicenter, double-blind randomized clinical trial. Assessment of safety. Am J Obstet Gynecol. 1993;169(1):26–33.
  • Wang ST, Johnson SJ, Mitchell D, et al. Cost-effectiveness of elagolix versus leuprolide acetate for treating moderate-to-severe endometriosis pain in the USA. J Comp Eff Res. 2019 Apr;8(5):337–355.
  • Crosignani P, Olive D, Bergqvist A, et al. Advances in the management of endometriosis: an update for clinicians. Hum Reprod Update. 2006 Mar-Apr;12(2):179–189.
  • Ács N, O’Brien C, Jiang P, et al. Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist: results from a phase 2, randomized controlled study. J Endometr Pelvic Pain Disord. 2015;7(2):56–62.
  • Carr BR, Stewart EA, Archer DF, et al. Elagolix alone or with add-back therapy in women with heavy menstrual bleeding and uterine leiomyomas: a randomized controlled trial. Obstet Gynecol. 2018 Nov;132(5):1252–1264.
  • Agarwal SK, Foster WG, Groessl EJ. Rethinking endometriosis care: applying the chronic care model via a multidisciplinary program for the care of women with endometriosis. Int J Womens Health. 2019;11:405–410.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.